Top in cardiology: Acute coronary syndrome trends, myocarditis after COVID-19 vaccination
Click Here to Manage Email Alerts
A new report suggests that most recurrent acute coronary syndrome events occur within 90 days of the initial event, and the statistical power to determine a treatment effect may be highest during this time.
It was the top story in cardiology last week.
Another top story covered new data on the prevalence of myocarditis after a messenger RNA-based COVID-19 vaccination. Although the absolute rates remain low, data showed a higher prevalence in male adolescents and young adults.
Read these and more top stories in cardiology below:
Data show ‘vulnerable window’ for recurrent ACS
The initial 90‐day window after acute coronary syndrome represents a vulnerable period for recurrent events, possibly attributable to atherothrombosis mechanisms not currently addressed with optimal therapy, researchers reported. Read more.
Myocarditis low after COVID-19 vaccination, but odds elevated in male teens, young adults
Despite low absolute rates, researchers observed elevated odds of cardiac injury among male adolescents and young adults after mRNA-based COVID-19 vaccination in a large U.S. study, as well as a smaller study in Hong Kong. Read more.
Anxiety elevates cardiometabolic risk over time in men
Higher levels of anxiety were linked to increases in cardiometabolic risk biomarkers over time in men, researchers reported in the Journal of the American Heart Association. Read more.
AHA: Shared risk factors contribute to rising global burden of brain disease, CVD
Heart disease continues to stand as the leading global cause of death, but there has been a rapid rise in brain disease-related deaths, and risk factors for both are similar, according to an American Heart Association report. Read more.
AHA advisory: Oral penicillin safer than injectable for high-risk rheumatic heart disease
Oral penicillin may be safer than the injectable option for people with rheumatic heart disease who are at high risk for a cardiac reaction, according to a new American Heart Association presidential advisory. Read more.